InVivo Therapeutics Holdings Corporation
InVivo Therapeutics Holdings Corporation (NVIV) Stock Overview
Explore InVivo Therapeutics Holdings Corporation’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
995.9K
P/E Ratio
-0.05
EPS (TTM)
$-3.28
ROE
-0.60%
NVIV Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of InVivo Therapeutics Holdings Corporation (NVIV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.15.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.05 and a market capitalization of 995.9K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.